Fentanyl Transdermal Matrix Patch ZR-02-01 to Treat Moderate to Severe Cancer Pain

NCT00126789 · clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
24
Enrollment
INDUSTRY
Sponsor class

Stopped Based on PK data, product did not meet requirement for further development.

Conditions

Interventions

Sponsor

ZARS Pharma Inc.